Clinical Outcome of Allogeneic SCT With a RIC Regimen in Young Adults With AML in CR1; Impact of Prior Consolidation Therapy

Biology of Blood and Marrow Transplantation - Netherlands
doi 10.1016/j.bbmt.2012.11.321
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Outcome of Allogeneic (Allo) Stem Cell Transplant (SCT) After Failure of a Prior SCT: A Single Center's Experience

Biology of Blood and Marrow Transplantation
TransplantationHematology
2009English

Pre-Transplant MRD Predicts Outcome Following Reduced-Intensity and Myeloablative Allogeneic Hemopoietic SCT in AML

Bone Marrow Transplantation
TransplantationHematology
2014English

An Identical Reduced Intensity Conditioning (RIC) Regimen Prior to Allogeneic (ALLO) Hematopoietic Stem Cell Transplantation (HSCT) in 222 Patients With Hematologic Malignancies: A Monocenter Experience

Biology of Blood and Marrow Transplantation
TransplantationHematology
2013English

Similar Outcomes Between Adolescent/Young Adults and Children With AML Following Allogeneic Hematopoietic Cell Transplantation

Bone Marrow Transplantation
TransplantationHematology
2013English

Anthracycline-Based Consolidation May Determine Outcome of Post-Consolidation Immunotherapy in AML

Leukemia and Lymphoma
Cancer ResearchOncologyHematology
2019English

No Evidence of Impact of Maraviroc on Outcome After Allogeneic Hematopoietic Stem Cell Transplant With Reduced Intensity Conditioning (RIC)

Biology of Blood and Marrow Transplantation
TransplantationHematology
2016English

Second Allogeneic Stem-Cell Transplantation (SCT) From a Different Donor for the Treatment of Relapsed AML and MDS After a Previous Allogeneic SCT

Biology of Blood and Marrow Transplantation
TransplantationHematology
2013English

Donor-Derived CD123-Targeted CAR T Cell Serves as a RIC Regimen for Haploidentical Transplantation in a Patient With FUS-ERG+ AML

Frontiers in Oncology
Cancer ResearchOncology
2019English

Impact of Pretransplant Comorbidities on Alemtuzumab-Based Reduced-Intensity Conditioning Allogeneic Hematopoietic SCT for Patients With High-Risk Myelodysplastic Syndrome and AML

Bone Marrow Transplantation
TransplantationHematology
2009English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy